Notas del episodio
In this episode, we discuss semaglutides, more commonly referred to by their brand names (Wegovy, Ozempic, etc.) have grown significantly in popularity. Originally designed and intended for managing diabetes in a more efficient and effective manner, they have begun to be prescribed for weight loss and have been heralded as a miracle cure for obesity. As with all miracle cures, the other side isn't as glamorous as we'd like to think. This episode digs into the science, culture, and sociology (and of course the ethics) of this pharmaceutical marvel and what it means for future care providers.
AUDIO:
INTRO Song is This Science by Coma-Media
OUTRO Song is Screening by Coma-Media
ACKNOWLEDGEMENT:
The Prehealth Podcast at Penn State is a production of Prehealth Advising in the Eber ...
... Leer más